Frontal White matter hyperintensities, clasmatodendrosis and gliovascular abnormalities in ageing and post-stroke dementia

Brain

Volumn 139, Issue 1, 2016, Pages 242-258

  Chen, Aiqing ^a   Akinyemi, Rufus O ^a   Hase, Yoshiki ^a   Firbank, Michael J ^a   Ndung'u, Michael N ^b   Foster, Vincent ^a   Craggs, Lucy J L ^a   Washida, Kazuo ^a   Okamoto, Yoko ^a   Thomas, Alan J ^a   Polvikoski, Tuomo M ^a   Allan, Louise M ^a   Oakley, Arthur E ^a   O'Brien, John T ^a   Horsburgh, Karen ^c   Ihara, Masafumi ^d   Kalaria, Raj N ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b INSTITUTE OF PRIMATE RESEARCH   (Kenya)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Ageing; Blood brain barrier; Clasmatodendrocyte; Post stroke dementia; White matter

Indexed keywords

ALDEHYDE DEHYDROGENASE 1 FAMILY MEMBER L1; ALDEHYDE DEHYDROGENASE ISOENZYME 1; AQUAPORIN 4; FIBRINOGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; UNCLASSIFIED DRUG; ALDEHYDE DEHYDROGENASE; ALDH1L1 PROTEIN, HUMAN;

ADULT; AGED; AGING; ANIMAL TISSUE; ARTICLE; ASTROCYTE; AUTOPSY; BABOON; BLOOD BRAIN BARRIER; BRAIN PERFUSION; CELL BODY; CELL VACUOLE; CEREBROVASCULAR ACCIDENT; CLASMATODENDROSIS; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOREACTIVITY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SURVIVAL TIME; SURVIVOR; WHITE MATTER; ANIMAL; CASE CONTROL STUDY; COGNITIVE DEFECT; COMPLICATION; DEMENTIA; FRONTAL LOBE; METABOLISM; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PAPIO ANUBIS; PATHOLOGY; VASCULARIZATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; ALDEHYDE DEHYDROGENASE; ANIMALS; AQUAPORIN 4; ASTROCYTES; BLOOD-BRAIN BARRIER; CASE-CONTROL STUDIES; COGNITION DISORDERS; DEMENTIA; FEMALE; FRONTAL LOBE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROIMAGING; NEUROPSYCHOLOGICAL TESTS; PAPIO ANUBIS; STROKE; WHITE MATTER;

EID: 84964596013     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awv328     Document Type: Article

References (58)

1. Abbott NJ, Ronnback L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006;7:41-53.
2. Akinyemi RO. Profile, determinants and mechanisms of cerebral injury and cognitive impairment following stroke. Institute of Neuroscience. Vol PhD thesis. Newcastle upon Tyne: Newcastle University, 2014. p. 280.
3. Allan LM, Rowan EN, Firbank MJ, Thomas AJ, Parry SW, Polvikoski TM, et al. Long term incidence of dementia, predictors of mortality and pathological diagnosis in older stroke survivors. Brain 2011;134:3716-27.
4. Badaut J, Lasbennes F, Magistretti PJ, Regli L. Aquaporins in brain: distribution, physiology, and pathophysiology. J Cereb Blood Flow Metab 2002;22:367-78.
5. Barker R, Ashby EL, Wellington D, Barrow VM, Palmer JC, Kehoe PG, et al. Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia. Brain 2014;137:1524-32.
6. Barker R, Wellington D, Esiri MM, Love S. Assessing white matter ischemic damage in dementia patients by measurement of myelin proteins. J Cereb Blood Flow Metab 2013;33:1050-7.
7. Bolandzadeh N, Davis JC, Tam R, Handy TC, Liu-Ambrose T. The association between cognitive function and white matter lesion location in older adults: a systematic review. BMC Neurol 2012;12:126.
8. Burke MJ, Nelson L, Slade JY, Oakley AE, Khundakar AA, Kalaria RN. Morphometry of the hippocampal microvasculature in poststroke and age-related dementias. Neuropathol Appl Neurobiol 2014;40:284-95.
9. Burton EJ, Kenny RA, O'Brien J, Stephens S, Bradbury M, Rowan E, et al. White matter hyperintensities are associated with impairment of memory, attention, and global cognitive performance in older stroke patients. Stroke 2004;35:1270-5.
10. de Leeuw FE, de Groot JC, Achten E, Oudkerk M, Ramos LM, Heijboer R, et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 2001;70:9-14.
11. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. Br Med J 2010;341:c3666.
12. DeCarli C, Murphy DG, Tranh M, Grady CL, Haxby JV, Gillette JA, et al. The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology 1995;45:2077-84.
13. Deramecourt V, Slade JY, Oakley AE, Perry RH, Ince PG, Maurage CA, et al. Staging and natural history of cerebrovascular pathology in dementia. Neurology 2012;78:1043-50.
14. El-Khoury N, Braun A, Hu F, Pandey M, Nedergaard M, Lagamma EF, et al. Astrocyte end-feet in germinal matrix, cerebral cortex, and white matter in developing infants. Pediatr Res 2006;59:673-9.
15. Firbank MJ, Allan LM, Burton EJ, Barber R, O'Brien JT, Kalaria RN. Neuroimaging predictors of death and dementia in a cohort of older stroke survivors. J Neurol Neurosurg Psychiatry 2012;83:263-7.
16. Firbank MJ, He J, Blamire AM, Singh B, Danson P, Kalaria RN, et al. Cerebral blood flow by arterial spin labeling in poststroke dementia. Neurology 2011;76:1478-84.
17. Foster V, Oakley AE, Slade JY, Hall R, Polvikoski TM, Burke M, et al. Pyramidal neurons of the prefrontal cortex in post-stroke, vascular and other ageing-related dementias. Brain 2014;137(Pt 9):2509-21.
18. Friede RL, van Houten WH. Relations between post-mortem alterations and glycolytic metabolism in the brain. Exp Neurol 1961;4:197-204.
19. Funfschilling U, Supplie LM, Mahad D, Boretius S, Saab AS, Edgar J, et al. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 2012;485:517-21.
20. Furuta A, Ishii N, Nishihara Y, Horie A. Medullary arteries in aging and dementia. Stroke 1991;22:442-6.
21. Gelot A, Villapol S, Billette de Villemeur T, Renolleau S, Charriaut-Marlangue C. Astrocytic demise in the developing rat and human brain after hypoxic-ischemic damage. Dev Neurosci 2009;31:459-70.
22. Gemmell E, Bosomworth H, Allan L, Hall R, Khundakar A, Oakley AE, et al. Hippocampal neuronal atrophy and cognitive function in delayed poststroke and aging-related dementias. Stroke 2012;43:808-14.
23. Hinson SR, Pittock SJ, Lucchinetti CF, Roemer SF, Fryer JP, Kryzer TJ, et al. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology 2007;69:2221-31.
24. Holland PR, Searcy JL, Salvadores N, Scullion G, Chen G, Lawson G, et al. Gliovascular disruption and cognitive deficits in a mouse model with features of small vessel disease. J Cereb Blood Flow Metab 2015;35:1005-14. doi: 10.1038/jcbfm.2015.12.
25. Hulse RE, Winterfield J, Kunkler PE, Kraig RP. Astrocytic clasmatodendrosis in hippocampal organ culture. Glia 2001;33:169-79.
26. Ihara M, Polvikoski TM, Hall R, Slade JY, Perry RH, Oakley AE, et al. Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer's disease, and dementia with Lewy bodies. Acta Neuropathol 2010;119:579-89.
27. Inzitari D, Pracucci G, Poggesi A, Carlucci G, Barkhof F, Chabriat H, et al. Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort. Br Med J 2009;339:b2477.
28. Kalaria RN, Ihara M. Dementia: vascular and neurodegenerative pathways-will they meet? Nat Rev Neurol 2013;9:487-8.
29. Kalaria RN, Kenny RA, Ballard CG, Perry R, Ince P, Polvikoski T. Towards defining the neuropathological substrates of vascular dementia. J Neurol Sci 2004;226:75-80.
30. Kalaria RN, Perry RH, O'Brien J, Jaros E. Atheromatous disease in small intracerebral vessels, microinfarcts and dementia. Neuropathol Appl Neurobiol 2012;38:505-8.
31. Khundakar A, Morris C, Oakley A, McMeekin W, Thomas AJ. Morphometric analysis of neuronal and glial cell pathology in the dorsolateral prefrontal cortex in late-life depression. Br J Psychiatry 2009;195:163-9.
32. Kim JE, Ryu HJ, Yeo SI, Kang TC. P2X7 receptor differentially modulates astroglial apoptosis and clasmatodendrosis in the rat brain following status epilepticus. Hippocampus 2011;21:1318-33.
33. Kraig RP, Chesler M. Astrocytic acidosis in hyperglycemic and complete ischemia. J Cereb Blood Flow Metab 1990;10:104-114.
34. Lace G, Savva GM, Forster G, de Silva R, Brayne C, Matthews FE, et al. Hippocampal tau pathology is related to neuroanatomical connections: an ageing population-based study. Brain 2009;132:1324-34.
35. Lucchinetti CF, Guo Y, Popescu BF, Fujihara K, Itoyama Y, Misu T. The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica. Brain Pathol 2014;24:83-97.
36. Misu T, Hoftberger R, Fujihara K, Wimmer I, Takai Y, Nishiyama S, et al. Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica. Acta Neuropathol 2013;125:815-27.
37. Mori S, Sadoshima S, Ibayashi S, Lino K, Fujishima M. Relation of cerebral blood flow to motor and cognitive functions in chronic stroke patients. Stroke 1994;25:309-17.
38. Ndung'u M, Hartig W, Wegner F, Mwenda JM, Low RW, Akinyemi RO, et al. Cerebral amyloid beta (42) deposits and microvascular pathology in ageing baboons. Neuropathol Appl Neurobiol 2012;38:487-99.
39. Okamoto Y, Yamamoto T, Kalaria RN, Senzaki H, Maki T, Hase Y, et al. Cerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarcts. Acta Neuropathol 2012;123:381-94.
40. Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol 2009;8:1006-18.
41. Penfield W. Neuroglia and microglia: the interstitial tissue of the central nervous system. In: Cowdry EV, editors. Special cytology: the form and functions of the cell in health and disease. New York: Paul B. Hoeber; 1928. p. 1033-1068.
42. Perry RH, Oakley AE. 'Newcastle brain map'. Neuropsychiatric disorders. London: Wolfe; 1993. p. 1-10.
43. Popescu BF, Bunyan RF, Guo Y, Parisi JE, Lennon VA, Lucchinetti CF. Evidence of aquaporin involvement in human central pontine myelinolysis. Acta Neuropathol Commun 2013;1:40.
44. Popescu BF, Parisi JE, Cabrera-Gomez JA, Newell K, Mandler RN, Pittock SJ, et al. Absence of cortical demyelination in neuromyelitis optica. Neurology 2010;75:2103-9.
45. Qin AP, Liu CF, Qin YY, Hong LZ, Xu M, Yang L, et al. Autophagy was activated in injured astrocytes and mildly decreased cell survival following glucose and oxygen deprivation and focal cerebral ischemia. Autophagy 2010;6:738-53.
46. Robinson CA, Adiele RC, Tham M, Lucchinetti CF, Popescu BF. Early and widespread injury of astrocytes in the absence of demyelination in acute haemorrhagic leukoencephalitis. Acta Neuropathol Commun 2014;2:52.
47. Sahlas DJ, Bilbao JM, Swartz RH, Black SE. Clasmatodendrosis correlating with periventricular hyperintensity in mixed dementia. Ann Neurol 2002;52:378-81.
48. Savva GM, Stephan BC. Epidemiological studies of the effect of stroke on incident dementia: a systematic review. Stroke 2010;41:e41-6.
49. Sjobeck M, Haglund M, Englund E. Decreasing myelin density reflected increasing white matter pathology in Alzheimer's disease-a neuropathological study. Int J Geriatr Psychiatry 2005;20:919-26.
50. Smallwood A, Oulhaj A, Joachim C, Christie S, Sloan C, Smith AD, et al. Cerebral subcortical small vessel disease and its relation to cognition in elderly subjects: a pathological study in the Oxford Project to Investigate Memory and Ageing (OPTIMA) cohort. Neuropathol Appl Neurobiol 2012;38:337-43.
51. Taniguchi M, Yamashita T, Kumura E, Tamatani M, Kobayashi A, Yokawa T, et al. Induction of aquaporin-4 water channel mRNA after focal cerebral ischemia in rat. Brain Res Mol Brain Res 2000;78:131-7.
52. Tomimoto H, Akiguchi I, Suenaga T, Nishimura M, Wakita H, Nakamura S, et al. Alterations of the blood-brain barrier and glial cells in white-matter lesions in cerebrovascular and Alzheimer's disease patients. Stroke 1996;27:2069-74.
53. Tomimoto H, Akiguchi I, Wakita H, Suenaga T, Nakamura S, Kimura J. Regressive changes of astroglia in white matter lesions in cerebrovascular disease and Alzheimer's disease patients. Acta Neuropathol 1997;94:146-52.
54. Tradtrantip L, Zhang H, Saadoun S, Phuan PW, Lam C, Papadopoulos MC, et al. Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica. Ann Neurol 2012;71:314-22.
55. Vataja R, Pohjasvaara T, Mantyla R, Ylikoski R, Leppavuori A, Leskela M, et al. MRI correlates of executive dysfunction in patients with ischaemic stroke. Eur J Neurol 2003;10:625-31.
56. Wardlaw JM, Doubal F, Armitage P, Chappell F, Carpenter T, Munoz Maniega S, et al. Lacunar stroke is associated with diffuse blood-brain barrier dysfunction. Ann Neurol 2009;65:194-202.
57. Yamamoto Y, Ihara M, Tham C, Low RW, Slade JY, Moss T, et al. Neuropathological correlates of temporal pole white matter hyperintensities in CADASIL. Stroke 2009;40:2004-11.
58. Yamashita T, Kamiya T, Deguchi K, Inaba T, Zhang H, Shang J, et al. Dissociation and protection of the neurovascular unit after thrombolysis and reperfusion in ischemic rat brain. J Cereb Blood Flow Metab 2009;29:715-25.